Patents
Patents for C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
03/2005
03/31/2005CA2521811A1 Haloalkyl containing compounds as cysteine protease inhibitors
03/29/2005US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents
03/24/2005WO2005012220A3 Cycloalkylidene compounds as modulators of estrogen receptor
03/24/2005WO2004041161A3 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
03/24/2005US20050065139 Antidiabetic agents; controlling carbohydrate metabolism
03/23/2005EP1515951A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors
03/23/2005CN1599735A Multi-functional thioxanthone photoinitiators
03/17/2005US20050059729 Substituted cyclic compounds
03/16/2005CN1596251A Piperazine derivatives having SST1 antagonistic activity
03/16/2005CN1594370A Thioxanthone photoinitiator containing aid initiator amino group and preparation method therefor
03/16/2005CN1193000C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cometic compositions containing same
03/10/2005US20050054690 Phenacyl 2-hydroxy-3-diaminoalkanes
03/10/2005US20050054536 Reacting an cyanoacrylate compound with amidine compound
03/10/2005US20050054018 Using cell cycle checkpoint activation modulators to prevent and treat cell proliferative disorders
03/08/2005US6864397 E.g., 1-(4-(4-pentylcyclohexyl)cyclohexyldifluoromethoxy)-4 -trifluoromethoxybenzene; preparation from difluorocyclo-hexylidenes, e.g. 1-(4-(trans-4-propylcyclohexyl)cyclohexyl-difluoromethoxy)-3,4,5 -trifluorobenzene; liquid crystals
03/03/2005WO2005019159A1 OPTICALLY ACTIVE α-AMINOOXYKETONE DERIVATIVES AND PROCESS FOR PRODUCTION THEREOF
03/03/2005US20050049252 Treating arthritis, pain and cancer; cyclooxygenase-2 inhibitors
03/03/2005US20050049238 Heterocyclic retinoid compounds
03/02/2005EP1510515A1 Phenylglycine derivatives as serine protease inhibitors
03/02/2005EP1509495A1 Anilino liver x-receptor modulators
03/02/2005EP0991636B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
03/02/2005CN1191232C Aminomethylcarboxylic acid derivatives
02/2005
02/24/2005WO2005017185A2 HEPATOCYTE NUCLEAR FACTOR 4α MODULATOR COMPOUNDS
02/23/2005EP1119350B1 Rar antagonists as male anti-fertility agents
02/23/2005CN1585746A Beta-amyloid protein production/secretion inhibitors
02/17/2005WO2005014559A1 Amide derivatives
02/16/2005EP1506959A2 Derivatised molecules for mass spectrometry
02/15/2005US6855832 O- or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
02/15/2005US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity
02/10/2005WO2005012220A2 Cycloalkylidene compounds as modulators of estrogen receptor
02/10/2005WO2004093856A3 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
02/10/2005US20050032860 CBI analogs of CC-1065 and the duocarmycins
02/10/2005US20050032855 Tetrahydro-2H-thiopyran-4-carboxamide derivative
02/10/2005US20050032848 Administering enzyme inhibitors of beta secretase, an enzyme responsible for the production of amyloid beta peptide by mediating the cleavage of amyloid precursor proteins; Alzheimer's disease; cognition activators; Down's syndrome; neurodegenerative diseases; other dementias of mixed origins
02/10/2005US20050032792 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases
02/10/2005US20050032772 Compounds useful as reversible inhibitors of cysteine proteases
02/09/2005CN1578776A Heterocyclic retinoid compounds
02/03/2005WO2005009983A1 Method for the detection of nucleophilic chemical species
02/03/2005WO2004094384A3 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease
02/03/2005US20050026876 9-aminomethyl substituted minocycline compounds
02/02/2005EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors
02/02/2005CN1575279A Substituted thioacetamides
02/01/2005US6849658 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them
02/01/2005US6849384 Photoacid generators, photoresist compositions containing the same and pattering method with the use of the compositions
01/2005
01/27/2005US20050020684 Modulators of peroxisome proliferator activated receptors
01/26/2005EP1500643A1 Benzamide derivatives
01/26/2005CN1569812A Aromatic tetramine monomer and aromatic tetramine chydrochloride and their preparation process
01/25/2005US6846843 β-thioamino acids
01/20/2005US20050014860 Nonmigrating; energy curable packaging varnishes, lacquers, printing inks; food applications
01/19/2005EP1498411A1 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
01/19/2005CN1185223C Novel Compounds and methods for synthesis and therapy
01/13/2005WO2005003125A1 Process for the preparation of 4,4-dimethyl-6-ethynylthiochroman
01/13/2005US20050010050 Antiinflammatory agents; antiarthritic agents; anticancer agents; analgesics
01/13/2005US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
01/13/2005US20050009820 Thiochromenones used to combat painful conditions and neurodegenerative diseases
01/12/2005EP1299373B1 Cyclic substituted aminomethyl compounds and medicaments containing said compounds
01/12/2005EP1171423B1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
01/12/2005CN1184200C Bi-aromatic compounds bond by a heteroethynytene radical and pharmaceutical and comsmetic compositions containing same
01/06/2005WO2005000233A2 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders
01/06/2005US20050004373 preparation of intermediates for tazarotene using a Vilsmeier Haack reaction.
01/06/2005US20050004203 NAALADase inhibitors; effecting transforming growth factor beta or neuronal activity
01/06/2005CA2530581A1 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders
01/05/2005CN1561246A Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease
01/05/2005CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors
12/2004
12/30/2004US20040266857 11,12-dehydro-naphtho[1,2-b]thioxane-9,10-dione derivatives; antiproliferative agents; psoriasis, cancer
12/29/2004WO2004113289A2 Glycosidase inhibitors and methods of synthesizing same
12/29/2004EP1274456B1 Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies
12/29/2004EP0874626B1 Use of inhibitors of retinoic acid activity for wound healing
12/29/2004CA2534094A1 Glycosidase inhibitors and methods of synthesizing same
12/23/2004WO2004111028A1 Cyclic onium compounds and glucosidase inhibitors
12/16/2004WO2004108661A1 Amidino compounds as cysteine protease inhibitors
12/16/2004WO2004087686A3 Benzopyran compounds useful for treating inflammatory conditions
12/16/2004US20040254327 Bisphenol a derivatives containing one biaryl group and a spacer; monomers for polycarbonates
12/16/2004US20040253730 Identifying modulators which induce apoptosis and activate cell cycle checkpoint systems; for use in treatment and prevention of cell proliferative disorders
12/16/2004US20040253216 Activated checkpoint therapy and methods of use thereof
12/16/2004CA2526694A1 Amidino compounds as cysteine protease inhibitors
12/15/2004CN1554651A Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
12/15/2004CN1179958C Cyclic substituted aminomethyl compounds and medicaments containing said compounds
12/08/2004EP0966420B1 2-arylcyclopentane-1,3-diones
12/08/2004CN1178902C New O-acyloxime photointiators
12/08/2004CN1178651C Lyophilized thioxanthenone anti-tumor agents
12/07/2004US6827876 Using alpha, alpha -difluorocyclohexylidene derivative as starting material to obtain difluoromethyl ether derivative
12/02/2004WO2004104051A1 Bimolecular photoinitiator systems
12/02/2004WO2004072031A3 Phenylacetamides and their use as glucokinase modulators
12/02/2004US20040242901 Sulfoniun salts, methods for their preparation and use thereof as phtoinitiators for radiation curable systems
12/01/2004EP1481973A1 Heterocycle-bearing onium salts
12/01/2004EP1481970A1 Novel herbicides
12/01/2004EP1480968A1 Thioxanthone derivatives, and their use as cationic photoinitiators
12/01/2004EP1480967A1 Novel fused ring compounds, and their use as cationic photoinitiators
12/01/2004EP1480944A2 Substituted aryl ketones
12/01/2004CN1177821C Matrix metalloprotease inhibitors
11/2004
11/30/2004US6825360 Bicyclic aromatic compounds
11/30/2004US6825354 Osteoporosis; rheumatic diseases
11/25/2004US20040235885 Novel composition and method for stabilizing the same
11/25/2004US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/23/2004US6822102 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of COX-2 mediated disorders
11/23/2004CA2105503C Carboxanilides, their preparation and compositions containing them for controlling harmful fungi
11/17/2004EP1274700B1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders
11/17/2004EP1210333B1 p-Tolyl-heterocycles as herbicides
11/16/2004US6818666 Bi-aromatic compounds linked via a heteroethylene radical, and pharmaceutical and cosmetic compositions using them
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 48